AU4781499A - Composition containing glycerol trinitrate, method for producing said composition and use of the same - Google Patents

Composition containing glycerol trinitrate, method for producing said composition and use of the same

Info

Publication number
AU4781499A
AU4781499A AU47814/99A AU4781499A AU4781499A AU 4781499 A AU4781499 A AU 4781499A AU 47814/99 A AU47814/99 A AU 47814/99A AU 4781499 A AU4781499 A AU 4781499A AU 4781499 A AU4781499 A AU 4781499A
Authority
AU
Australia
Prior art keywords
composition
producing
same
containing glycerol
glycerol trinitrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47814/99A
Other languages
English (en)
Inventor
Achim Berthold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU4781499A publication Critical patent/AU4781499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47814/99A 1998-07-09 1999-07-02 Composition containing glycerol trinitrate, method for producing said composition and use of the same Abandoned AU4781499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19830648 1998-07-09
DE19830648A DE19830648A1 (de) 1998-07-09 1998-07-09 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1999/004610 WO2000002537A1 (de) 1998-07-09 1999-07-02 Glyceroltrinitrathaltige zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
AU4781499A true AU4781499A (en) 2000-02-01

Family

ID=7873427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47814/99A Abandoned AU4781499A (en) 1998-07-09 1999-07-02 Composition containing glycerol trinitrate, method for producing said composition and use of the same

Country Status (15)

Country Link
EP (1) EP1094793A1 (es)
JP (1) JP2002520268A (es)
KR (1) KR20010074687A (es)
CN (1) CN1308526A (es)
AU (1) AU4781499A (es)
BR (1) BR9911984A (es)
CA (1) CA2336704A1 (es)
DE (1) DE19830648A1 (es)
HU (1) HUP0104950A3 (es)
IL (1) IL140739A0 (es)
MX (1) MXPA01000127A (es)
PL (1) PL345545A1 (es)
TR (1) TR200100020T2 (es)
WO (1) WO2000002537A1 (es)
ZA (1) ZA200100173B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
WO2010109544A1 (ja) * 2009-03-27 2010-09-30 株式会社メドレックス 核酸を有効成分とする外用剤組成物
JP5816881B2 (ja) * 2014-05-21 2015-11-18 株式会社 メドレックス 核酸を有効成分とする外用剤組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
EP0588839B1 (de) * 1991-06-10 1995-08-16 Schwarz Pharma Ag Nitroglycerin-pflaster und verfahren zu seiner herstellung
DE856311T1 (de) * 1996-12-10 1999-02-25 Rotta Res Bv Transdermales Arzneistoff-Verabreichungssystem zur Behandlung von Herzerkrankungen

Also Published As

Publication number Publication date
HUP0104950A2 (en) 2002-06-29
DE19830648A1 (de) 2000-01-13
KR20010074687A (ko) 2001-08-09
PL345545A1 (en) 2001-12-17
WO2000002537A1 (de) 2000-01-20
EP1094793A1 (de) 2001-05-02
CA2336704A1 (en) 2000-01-20
MXPA01000127A (es) 2002-06-04
BR9911984A (pt) 2001-03-27
IL140739A0 (en) 2002-02-10
JP2002520268A (ja) 2002-07-09
TR200100020T2 (tr) 2001-07-23
HUP0104950A3 (en) 2002-07-29
ZA200100173B (en) 2001-08-10
CN1308526A (zh) 2001-08-15

Similar Documents

Publication Publication Date Title
AU3897597A (en) Catalyst composition and method for its manufacturing
AU694837B2 (en) Naphthyl compounds, intermediates, compositions, and methods
AU3945197A (en) Novel stable liquid paracetamol compositions, and method for preparing same
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
AU5253499A (en) Method for improving the fade resistance of hair and related compositions
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU6111699A (en) Novel method and compounds
AU2524497A (en) Size composition, method for its preparation, and use thereof
AU3031899A (en) Nanoparticles, method for producing nanoparticles and use of the same
AU1278100A (en) 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses
AU8019598A (en) Composition and method for providing glutamine
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
AU1148099A (en) Powder varnish composition, method for producing and the use thereof
HUP0001551A3 (en) Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same
AU4328497A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU7688098A (en) Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU5176299A (en) Compound, composition and use
AU4781499A (en) Composition containing glycerol trinitrate, method for producing said composition and use of the same
AU4198899A (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU3044199A (en) Mastic composition and method of preparing same
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof
AU2001245474A1 (en) Method and composition for lightening the skin

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted